Artemether lumefantrine drug

As a critical antimalarial treatment, the product must adhere to WHO-PQ (Prequalification) or be manufactured in a facility with GMP (Good Manufacturing Practice) certification. Ensure the active pharmaceutical ingredients (APIs) meet International Pharmacopoeia (Ph. Int.), USP, or BP standards. Buyers should verify the Certificate of Analysis (CoA) for every batch to confirm the correct ratio (typically 20mg Artemether to 120mg Lumefantrine per tablet).

Artemether is sensitive to heat and moisture. The drug must be housed in Tropical Zone IVB compliant packaging (e.g., Alu-Alu blisters) to ensure a shelf life of 24 to 36 months. Technical documentation should include stability testing data under accelerated conditions (40°C ± 2°C / 75% RH ± 5% RH) to guarantee efficacy in tropical climates where malaria is endemic.

Buyers must choose between fixed-dose combinations (FDC) to ensure patient compliance. For pediatric use, dispersible tablets are preferred over standard oral tablets. It is vital to confirm the dissolution rate and bioavailability data provided by the manufacturer to ensure the drug reaches therapeutic levels in the bloodstream rapidly to combat Plasmodium falciparum.

Suppliers must provide a Product Dossier in CTD (Common Technical Document) format. Essential documents include the CPP (Certificate of Pharmaceutical Product) issued by the regulatory authority of the exporting country, and the Marketing Authorization (MA). For cross-border trade via Made-in-China.com, ensure the supplier is a verified manufacturer with a valid Drug Manufacturing License.

The most significant risks include counterfeit products and substandard formulations. To mitigate this, always conduct third-party laboratory testing (e.g., SGS or Intertek) before shipment. Additionally, be aware of Cold Chain requirements; although Artemether Lumefantrine is generally shelf-stable, extreme temperatures during transit can degrade the API, so temperature-controlled containers or data loggers are recommended for large sea-freight shipments.

Focus negotiations on Quality Assurance (QA) protocols rather than just price. Request a long-term supply agreement that includes clauses for batch consistency and recalled product compensation. For bulk orders, aim for staggered payment terms (e.g., 30% deposit, 70% after successful third-party inspection and before BL release) to ensure financial security.

Pharmaceuticals are highly regulated. You must ensure the importer has a Wholesale Dealer’s License (WDL) or an Import Permit from the local Ministry of Health (e.g., NAFDAC in Nigeria or FDA in Ghana). Ensure the HS Code (typically 3004.90) is correctly declared to avoid customs seizures. All shipping documents must include a Packing List, Commercial Invoice, and the CoA.

Utilize secure payment escrow services provided by professional B2B platforms like Made-in-China.com to protect your funds until the shipping documents are verified. Avoid using untraceable payment methods. Always verify the supplier's business scope to ensure they are legally authorized to export 'Finished Pharmaceutical Products' (FPP) and not just chemical intermediates.